Atrium Medical Center Participates in Cancer Research Study
Middletown, Ohio, March 26, 2013 – In recognition of National Colorectal Cancer Awareness Month, Atrium Medical Center, in conjunction with the Dayton Clinical Oncology Program, has launched a colorectal cancer research study. The purpose of the study is to find out if blood, urine or stool can be used to find colon cancer as early or earlier than a colonoscopy.
To qualify, participants must be between the ages of 50 and 80 and not have had a colonoscopy within the last three years. They must be scheduled for a colonoscopy and be willing to provide blood, urine and stool samples prior to the colonoscopy. Participants also must not have:
- A history of inflammatory bowel disease
- Obvious rectal bleeding
- Previous colon surgery
- Previous cancer
The study is being conducted by Albert Malcolm, MD, Medical Director of the Infusion Treatment Center and Chairman of the Cancer Committee at Atrium Medical Center, in conjunction with the Dayton Clinical Oncology Program, to promote health and wellness as well as cancer prevention.
According to the Centers for Disease Control and Prevention (CDC), as many as 60 percent of deaths from colorectal cancer could be prevented if everyone age 50 and older were screened regularly.
To learn more about the research study, contact Sandy Fletcher, BSN, RN, OCN, CCRP, of the Clinical Research Center at Atrium Medical Center at (513) 420-5674(513) 420-5674 or slfletcher@AtriumMedCenter.org.
Content Updated: May 4, 2016